Total Funding
30
41
Total FundingVenture - Series Unknown raised
Growth Score
-4 pts
Heat Score
-17 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
137538
Sequella is a biopharmaceutical company developing products for the diagnosis and treatment of epedemic infectious diseases.
- Leo Einck: Co-Founder, Director, and Chief Scientific Officer
- Carol Nacy: Co-Founder, Chief Executive Officer
About the Company
Sequella is a clinical-stage biopharmaceutical company, develops products for the diagnosis and treatment of infectious diseases. The company focuses on commercializing treatment paradigms for diseases of epidemic potential.
The company was founded in 1997 and headquartered in Rockville, Maryland.
Women Founded
